drug approvals

Biotech

The FDA's decision on aducanumab will drag down science

The amyloid theory just won’t die. In fact, by approving Biogen's new Alzheimer's drug, the FDA has resurrected it for a long and healthy future.
Ben Adams Jun 9, 2021 8:45am

Aducanumab approval appears to boost Biogen's AD competitors

Jun 7, 2021 1:00pm
image-icon

New drug approvals hit a high note in 2020 but face uncertainty

Jan 4, 2021 6:00am

New commish, COVID-19, bad comms hitting FDA speedy approvals

Aug 26, 2020 8:40am

EMA starts accelerated review of Gilead's remdesivir

May 1, 2020 6:00am

Giuliani-promoted COVID-19 therapy nabs FDA speedy start

Apr 2, 2020 9:00am